Fat: It's Not For Breakfast Anymore; Study Finds Fat Linked To Clotting

olenic acid (found in corn, canola and other vegetable oils).

The high-fat breakfasts consisted of a bun, margarine, jam, cake and orange juice. A control or "low-fat breakfast" that included a low-fat bun and yogurt was also tested. Four different margarines were used and buns and the cakes were baked with these margarines.

Factor VIIa levels were calculated by subtracting the levels of factor VIIa taken before the meal and levels taken at 1 and 3 p.m.

The Factor VIIa responses rose significantly -- about 11 to 16 milli unit (mU/mL) -- in those who ate the high-fat diets. In contrast, levels were lowered by about 6 mU/ml in the control diet.

"But most importantly, there were no differences among the fat-rich breakfasts," according to Mennen. "The results of our trial support the view that the factor VIIa response to a high dietary fat intake is independent of the type of fat," says Mennen, who adds that this response would probably occur after any fat-rich meal, not just breakfast.

He stresses that there is not enough information to know if a fat-rich meal increases a person's risk of heart disease directly, since the study only looked at the association between fat and factor VIIa.

"It is not clear if factor VIIa is a causal risk factor for heart disease, but if it were, this would mean that individuals would be at risk for heart attack after a fat-rich meal," he says.

Co-authors are Dr. Moniek de Maat; Dr. Gert Meijer; Dr. Peter Zock; Dr. Diederick Grobbee, Dr. Frans Kok; Dr. Cornelis Kluft; and Dr. Evert Schouten.


Contact: Carole Bullock
American Heart Association

Page: 1 2

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
TAG: Fat Not For Breakfast Anymore Study Finds Fat Linked Clotting

(Date:10/9/2015)... ... October 09, 2015 , ... MMJ ... Innovations with Ed Begley Jr., airing 1st QT 2016 via the Discovery Channel. ... on MMJ Phytotech Limited (MMJ) – a global leader in the field of ...
(Date:10/9/2015)... ... 2015 , ... Ryan Fox, the founder and CEO of ... says the latest figures on the state’s sales of legalized marijuana acknowledge that ... , Last month, according to the website AllGov.com , Colorado's Department ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... Most people ... processed with more vegetables and less meat. While noted T’ai Chi Master and integrative ... “Yin and Yang” relationship between the two cuisines and that they potentially complement one ...
(Date:10/9/2015)... Florida (PRWEB) , ... October 09, 2015 , ... A variety of race options will ... Treatment of Co-occurring Disorders on Sunday, October 18, at Al Lopez Park, 4810 North Himes ... and will include the choice of a 5K run or walk and a one-mile walk, ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... of Kimberly Post, CPA , as Chief Financial Officer. Kimberly will ... compliance and assist with any strategic acquisitions. Kimberly’s experience guiding healthcare services ...
Breaking Medicine News(10 mins):
(Date:10/8/2015)... Calif. , Oct. 8, 2015  Ardelyx, ... company focused on gastrointestinal and cardio-renal diseases, today ... product candidate, tenapanor, will be presented at the ... presented findings will include measures of sustained response ... double blind, placebo-controlled, randomized Phase 2 trial. The ...
(Date:10/8/2015)... 8, 2015  Trovagene, Inc., (NASDAQ:   TROV) ... the presentation of results from a field experience ... Monitoring SM (PCM) platform to accurately identify ... to determine appropriate therapy for patients. Mark ... is delivering the results today in an oral ...
(Date:10/8/2015)... Oct. 8, 2015  Following months of investigation, Ross ... the nation alleging that the anticoagulant Xarelto,s recommended dosage doesn,t ... Philadelphia on behalf of a ... stroke because the drug didn,t work as the manufacturer suggested. ... other suits shortly on behalf of clients from across the ...
Breaking Medicine Technology:
Cached News: